I. Kirk

发表

Responses in a Canine Model Ticagrelor Inhibits Adenosine Uptake In Vitro and Enhances Adenosine-Mediated Hyperemia

J. Sidaway, J. Björkman, P. Glaves, 2012 .

Ticagrelor Inhibits Adenosine Uptake In Vitro and Enhances Adenosine-Mediated Hyperemia Responses in a Canine Model

J. Sidaway, J. Björkman, J. V. van Giezen, 2012, Journal of cardiovascular pharmacology and therapeutics.

From ATP to AZD6140: the discovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosis.

P. Leeson, B. Springthorpe, P. Barton, 2007, Bioorganic & medicinal chemistry letters.

Abstract 245: AZD6140 Inhibits Adenosine Uptake Into Erythrocytes and Enhances Coronary Blood Flow After Local Ischemia or Intracoronary Adenosine Infusion

J. Björkman, J. V. Giezen, I. Kirk, 2007 .

P2Y1‐receptors in human platelets which are pharmacologically distinct from P2YADP‐receptors

M. J. Robertson, P. Leff, R. G. Humphries, 1998, British journal of pharmacology.

Adenosine A2a Receptor‐Mediated Modulation of Striatal [3H]GABA and [3H]Acetylcholine Release

P. Richardson, I. Kirk, 1994, Journal of neurochemistry.

Inhibition of Striatal GABA Release by the Adenosine A2a Receptor Is Not Mediated by Increases in Cyclic AMP

I. Kirk, P. J. Richardson, 1995, Journal of neurochemistry.

Inhibition by KF17837 of adenosine A2A receptor‐mediated modulation of striatal GABA and ACh release

H. Kase, M. Kurokawa, I. Kirk, 1994, British journal of pharmacology.

The C6‐2B glioma cell P2YAC receptor is pharmacologically and molecularly identical to the platelet P2Y12 receptor

S. Kunapuli, R. G. Humphries, Jianguo Jin, 2001, British journal of pharmacology.

Further characterization of [3H]‐CGS 21680 binding sites in the rat striatum and cortex

I. Kirk, P. J. Richardson, 1995, British journal of pharmacology.